| Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes NCT01272219 | Completed | P3 | Novo Nordisk A/S |
| Liraglutide Treatment in Obese Infertile PCOS Women NCT06742710 | Recruiting | P4 | Peking University Third Hospital |
| Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes NCT01272232 | Completed | P3 | Novo Nordisk A/S |
| Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity. NCT03856047 | Completed | P2 | Novo Nordisk A/S |
| The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes NCT00422058 | Completed | P2 | Novo Nordisk A/S |
| A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants NCT03486392 | Completed | P2 | Janssen Research & Development, LLC |
| Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance NCT00781937 | Completed | P3 | Novo Nordisk A/S |
| The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients NCT04605861 | Completed | P3 | Shanghai Zhongshan Hospital |
| Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin NCT02963922 | Completed | P3 | Novo Nordisk A/S |
| Saxenda in Obesity Services (STRIVE Study) NCT03036800 | Completed | P4 | University of Leicester |
| Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea NCT01557166 | Completed | P3 | Novo Nordisk A/S |
| Cardiovascular Effects of GLP-1 Receptor Activation NCT03101930 | Completed | P4 | Vanderbilt University Medical Center |
| Gut Microbiome Changes Following Liraglutide Treatment in Obese Subjects or Overweight Subjects With Co-morbidities NCT04525300 | Unknown | P3 | Xiangya Hospital of Central South University |
| Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities NCT04487743 | Unknown | P3 | Xiangya Hospital of Central South University |
| Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting NCT02963935 | Completed | P3 | Novo Nordisk A/S |
| Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity NCT02918279 | Completed | P3 | Novo Nordisk A/S |
| Impact of Liraglutide 3.0 on Body Fat Distribution NCT03038620 | Completed | P4 | University of Texas Southwestern Medical Center |
| Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet NCT04122716 | Unknown | P4 | Signe Torekov |
| Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity NCT05111912 | Completed | P2 | Sciwind Biosciences APAC CO Pty. Ltd. |
| Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity NCT03799198 | Completed | P4 | Novo Nordisk A/S |
| Individualized Obesity Pharmacotherapy NCT03374956 | Completed | P3 | Mayo Clinic |
| Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility NCT05952882 | Unknown | P3 | Mỹ Đức Hospital |
| Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD) NCT03087032 | Recruiting | P4 | The First Affiliated Hospital of Xiamen University |
| Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients NCT03671733 | Unknown | P3 | Xiangya Hospital of Central South University |
| Lifestyle Modification and Liraglutide NCT02911818 | Completed | P4 | University of Pennsylvania |
| Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance NCT02928679 | Completed | P4 | Henrik Gudbergsen |
| Liraglutide 3 mg for Knee Osteoarthritis NCT02905864 | Completed | P4 | Henrik Gudbergsen |
| Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Maintenance NCT02928614 | Completed | P4 | Henrik Gudbergsen |
| Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance NCT02931383 | Completed | P4 | Henrik Gudbergsen |
| Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity NCT03523273 | Completed | P2 | Michael Camilleri, MD |
| Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery NCT03048578 | Completed | P4 | NYU Langone Health |
| RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients. | Not yet recruiting | P4 | The Fourth Affiliated Hospital of Zhejiang University School of Medicine |
| Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease NCT06501326 | Unknown | P4 | Affiliated Hospital of Nantong University |
| Liraglutide in Type 1 Diabetes NCT01612468 | Completed | P4 | Steno Diabetes Center Copenhagen |
| Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes NCT02014740 | Completed | P4 | University of Miami |
| Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic Surgery NCT07374445 | Completed | P4 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |
| Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes NCT02503943 | Unknown | P4 | Third Affiliated Hospital of Third Military Medical University |
| Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS NCT03480022 | Completed | P3 | Woman's |
| SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity NCT04775082 | Active, not recruiting | P3 | Novo Nordisk A/S |
| EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial NCT04531176 | Terminated | P4 | The Cleveland Clinic |
| Preoperative Use of Liraglutide Additionally to Common Dietological Measures as Opposed to Dietological Measures Alone NCT06865365 | Not yet recruiting | P4 | Medical University of Vienna |
| Randomisation to Endobarrier Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity) NCT02055014 | Unknown | P4 | Sandwell & West Birmingham Hospitals NHS Trust |
| Adding Liraglutide to High Dose Insulin: Breaking the Cycle NCT01505673 | Completed | P4 | Ildiko Lingvay |
| The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS NCT03151005 | Completed | P4 | Xinqiao Hospital of Chongqing |
| Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response NCT03341429 | Completed | P4 | University College, London |
| Effect of Liraglutide on Microbiome in Obesity NCT04046822 | Unknown | P4 | Federico II University |
| Reward Mechanisms in Obesity NCT03347890 | Completed | P4 | Zoltan Pataky |
| Effects of Benaglutide on Weight and Gut Microbiota in Obese Patients NCT03986008 | Unknown | P3 | Xiangya Hospital of Central South University |
| Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated) NCT03158805 | Completed | P2 | Lindner Center of HOPE |
| Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome NCT02527200 | Completed | P3 | Novo Nordisk A/S |
| To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes NCT01725126 | Completed | P2 | GlaxoSmithKline |
| Preoperative Condition in Giant Obese Patients NCT02616003 | Completed | P4 | Sana Klinikum Offenbach |
| GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations NCT02082496 | Completed | P2 | University of Copenhagen |
| Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes NCT02674893 | Terminated | P4 | Centre Hospitalier Universitaire Dijon |
| Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy NCT03115424 | Completed | P3 | Mayo Clinic |
| PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome NCT02187250 | Completed | P4 | University Medical Centre Ljubljana |
| LIROH - Liraglutide for Obesity in HIV NCT06438146 | Unknown | P4 | Brigham and Women's Hospital |
| Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome NCT02483299 | Completed | P4 | University Medical Centre Ljubljana |
| Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity NCT02647944 | Completed | P2 | Mayo Clinic |
| Study of the Cardiometabolic Effects of Obesity Pharmacotherapy NCT04575194 | Unknown | P4 | National and Kapodistrian University of Athens |